Steven M. Seiler

3.1k total citations · 1 hit paper
71 papers, 2.6k citations indexed

About

Steven M. Seiler is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Steven M. Seiler has authored 71 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 22 papers in Hematology and 21 papers in Organic Chemistry. Recurrent topics in Steven M. Seiler's work include Blood Coagulation and Thrombosis Mechanisms (20 papers), Chemical Synthesis and Analysis (14 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers). Steven M. Seiler is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (20 papers), Chemical Synthesis and Analysis (14 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers). Steven M. Seiler collaborates with scholars based in United States, Germany and Sweden. Steven M. Seiler's co-authors include Sidney Fleischer, A Saito, Alice Chu, Nicholas A. Meanwell, Larry R. Jones, Ernest R. Keeley, David R. Hathaway, Marianne E. Federici, Karen S. Hartl and Inge M. Michel and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Journal of Molecular Biology.

In The Last Decade

Steven M. Seiler

71 papers receiving 2.5k citations

Hit Papers

Preparation and morphology of sarcoplasmic reticulum term... 1984 2026 1998 2012 1984 100 200 300 400 500

Peers

Steven M. Seiler
Michael P. Graziano United States
Robert L. Dow United States
Simone Rost Germany
Michael L. Jennings United States
John W. Kyle United States
C. James Hastie United Kingdom
Marcus F. Boehm United States
Michael P. Graziano United States
Steven M. Seiler
Citations per year, relative to Steven M. Seiler Steven M. Seiler (= 1×) peers Michael P. Graziano

Countries citing papers authored by Steven M. Seiler

Since Specialization
Citations

This map shows the geographic impact of Steven M. Seiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Seiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Seiler more than expected).

Fields of papers citing papers by Steven M. Seiler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Seiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Seiler. The network helps show where Steven M. Seiler may publish in the future.

Co-authorship network of co-authors of Steven M. Seiler

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Seiler. A scholar is included among the top collaborators of Steven M. Seiler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Seiler. Steven M. Seiler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sutton, James, Gregory S. Bisacchi, Bruce L. Jacobson, et al.. (2013). Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffold. Bioorganic & Medicinal Chemistry Letters. 23(18). 5239–5243. 12 indexed citations
2.
O’Connor, Stephen P., Karnail S. Atwal, Chi Li, et al.. (2008). Synthesis and evaluation of acylguanidine FXa inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(16). 4696–4699. 7 indexed citations
3.
Seiler, Steven M. & Ernest R. Keeley. (2007). A comparison of aggressive and foraging behaviour between juvenile cutthroat trout, rainbow trout and F1 hybrids. Animal Behaviour. 74(6). 1805–1812. 26 indexed citations
4.
Bisacchi, Gregory S., William A. Slusarchyk, Karen S. Hartl, et al.. (2004). Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase. Bioorganic & Medicinal Chemistry Letters. 14(9). 2227–2231. 27 indexed citations
5.
Slusarchyk, William A., Karen S. Hartl, Ming‐Hsing Huang, et al.. (2002). Synthesis of potent and highly selective inhibitors of human tryptase. Bioorganic & Medicinal Chemistry Letters. 12(21). 3235–3238. 41 indexed citations
6.
Das, Jagabandhu, S. David Kimball, Steven E. Hall, et al.. (2002). Molecular design and structure–Activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664. Bioorganic & Medicinal Chemistry Letters. 12(1). 45–49. 10 indexed citations
7.
Keh, Didier, Max Gerlach, Steven M. Seiler, et al.. (1996). The effects of nitric oxide (NO) on platelet membrane receptor expression during activation with human ??-thrombin. Blood Coagulation & Fibrinolysis. 7(6). 615–624. 30 indexed citations
8.
Trehan, Ashok K., et al.. (1995). Azetidin-2-one derivatives as inhibitors of thrombin. Bioorganic & Medicinal Chemistry. 3(8). 1123–1143. 131 indexed citations
9.
Laurent, Denis R. St., Niranjan Balasubramanian, Wenfei Han, et al.. (1995). Active site-directed thrombin inhibitors-II. Studies related to arginine/guanidine bioisosteres. Bioorganic & Medicinal Chemistry. 3(8). 1145–1156. 15 indexed citations
10.
Iwanowicz, Edwin J., et al.. (1994). Retro-Binding Tripeptide Thrombin Active-Site Inhibitors: Discovery, Synthesis, and Molecular Modeling. Journal of Medicinal Chemistry. 37(14). 2122–2124. 18 indexed citations
12.
Schumacher, William A., et al.. (1994). Effect of a novel thrombin active-site inhibitor on arterial and venous thrombosis. European Journal of Pharmacology. 259(2). 165–171. 10 indexed citations
13.
Balasubramanian, Niranjan, Denis R. St. Laurent, Marianne E. Federici, et al.. (1993). Active site-directed synthetic thrombin inhibitors: synthesis, in vitro and in vivo activity profile of BMY 44621 and analogs. An examination of the role of the amino group in the D-Phe-Pro-Arg-H series. Journal of Medicinal Chemistry. 36(2). 300–303. 43 indexed citations
14.
Webb, Maria L., Hossain Monshizadegan, Kenneth E.J. Dickinson, et al.. (1993). Binding and signal transduction of the cloned vascular angiotensin II (AT1a) receptor cDNA stably expressed in Chinese hamster ovary cells. Regulatory Peptides. 44(2). 131–139. 8 indexed citations
15.
Meanwell, Nicholas A., Piyasena Hewawasam, James A. Thomas, et al.. (1993). Inhibitors of blood platelet cAMP phosphodiesterase. 4. Structural variation of the side-chain terminus of water-soluble 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-one derivatives. Journal of Medicinal Chemistry. 36(22). 3251–3264. 9 indexed citations
16.
Fleming, John, et al.. (1991). Antithrombotic activity of BMY-43351, a new imidazoquinoline with enhanced aqueous solubility. Thrombosis Research. 63(1). 145–155. 4 indexed citations
17.
18.
Seiler, Steven M., et al.. (1990). SQ-27986 inhibition of platelet aggregation is mediated through activation of platelet prostaglandin D2 receptors. Prostaglandins. 40(2). 119–130. 14 indexed citations
19.
Fleming, John, et al.. (1989). Pharmacology of a potent, new antithrombotic agent, 1,3-dihydro-7,8-dimethyl-2-imidazo[4,5-]quinolin-2-one (BMY-20844). Thrombosis Research. 56(3). 333–346. 11 indexed citations
20.
Seiler, Steven M., et al.. (1987). Inhibitors of inositol trisphosphate-induced Ca2+ release from isolated platelet membrane vesicles. Biochemical Pharmacology. 36(20). 3331–3337. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026